Practices that were once common amongst major corporations across the world, such as offering stock options to employees, have dwindled in terms of usage due to accounting costs and a multitude of additional issues, changing the landscape of employment throughout the corporate world. When it comes to stock options, there are usually several prominent reasons that companies have discontinued the practice. Due to overall volatility of the stock market, stock values may fluctuate considerably, and in the case that the value drops significantly, stockholders may face issues such as option overhang.
The best solution to combating the issues associated with offering stock options could be for employers to include a knockout option. If a knockout option is included, once a stock drops below a certain price, the option is rendered obsolete, saving the company from increased accounting costs, as well as protecting stockholders that are not employed by the company from option overhang. Including a knockout clause will also create decreased compensation figures for executives, while also offering a more accurate reflection of the company’s earnings.
An expert on the law concerning corporate governance and executive compensation, the founder of Jeremy L. Goldstein and Associates, LLC, Jeremy Goldstein, has been a major factor in some of the most important world’s most important corporate transactions to occur over the last decade. His boutique law firm provides sound financial advice to CEO’s, compensation committees, and management teams, during times in which sensitive situations arise, as well as during significant corporate events. Prior to founding Jeremy L. Goldstein and Associates, LLC, Mr. Goldstein was a partner with Wachtell, Lipton, Rosen, and Katz. Jeremy L. Goldstein is a graduate of Cornell University, where he received his B.A. cum laude, and he later attended New York University School of Law. He also received his M.S. from the University of Chicago. Throughout his career, Jeremy Goldstein has received a number of awards and honors, including being recognized as one of the top executive compensation lawyers in the United States by The Legal 500, as well as Chambers USA Guide to America’s Leading Lawyers for Business. He is a frequent contributor of articles regarding executive compensation and corporate governance on a multitude of online platforms, and he is a member of the Professional Advisory Board of the NYU Journal of Law and Business, as well as being an active board member at Fountain House; a charity that focuses on recovery from mental illness.
Visit http://officialjeremygoldstein.com/ to learn more.
The name Lime Crime is associated with fantastic colors and high-quality cosmetics that have fans of the makeup company clamoring to grab all of their newest products. The force behind the brand is the ever-colorful and business savvy Doe Deere.
Doe Deere was a business minded individual even when she was a child. She remembers selling temporary tattoos to her friends and schoolmates when they first made an arrival on the market. She also had a flair for color and design. At slumber parties when she was young, she and her friends would experiment with makeup colors and clothes. It was obvious that she was destined to be a force to be reckoned with in the makeup industry. That fierce entrepreneurial spirit would follow her from her home in Russia, to the United States when she was just 19 years old.
Once she settled into the area as a punk musician, she began to integrate her unique flair for makeup and clothing into her act. It was difficult for her to find the right makeup to help her piece together the looks she wanted, so she decided to start making her own makeup. Along the way, she decided to upload tutorial videos to YouTube. Once she was on the social media platform, she began to become a YouTube sensation. People were asking if they could buy her makeup creations, so she started selling her makeup on Ebay. She decided on the name of the company, Lime Crime because she needed a name for her new company. She rhymed her favorite color with the first word that popped into her head and the name Lime Crime was born.
Doe Deere never realized that her makeup would become a huge success. With the proper marketing techniques, which she picked up along the way during her band days, and some elbow grease, she became an incredible success. She never dreamed that one day she would create a company that would be a major name in the makeup industry. Lime Crime is notorious for its brightly colored lip and eye makeup, a well as hair dye and other assorted products that other companies shy away from providing to their customers.
There is now a cult following for Lime Crime cosmetics and the company continues to grow and thrive. The products are all cruelty-free and dermatologist tested, and Doe herself works through every step of the creation and distribution process to ensure her company delivers only the highest quality products. She is even willing to test the new offerings on herself before releasing them to the public. Through hard work and perseverance, Doe Deere has created an incredibly successful company and has proven to be a top entrepreneur in the world today.
Visit https://www.limecrime.com/about/ to learn more.
Scott M. Rocklage Ph.D. is managing partner at 5AM Venture Management LLC. He joined the company as a venture partner and was promoted to his current position in 2004.
Rocklage graduated from UC Berkley with a bachelor’s degree in chemistry and went on to M.I.T. where he earn a Ph.D. in Chemistry. While at M.I.T., Rocklage worked in the lab of Richard R. Schrock, the Nobel Prize winner, doing research. Dr. Rocklage holds more than 30 U.S. patents and his work has appeared in over 100 peer-reviewed publications. He has also helped get FDA approval for several drugs.
Prior to working with 5AM Venture Management, Dr. Rocklage held executive positions with several biotech companies. He was CEO of EPIRUS Biopharmaceuticals, president and CEO of Amersham Health and co-president of Ilypsa. Dr. Rocklage also served as founding CEO and president of Cubist Pharmaceuticals. He was also Nycomed Salutar’s president and CEO and served as Nycomed Interventional’s CEO, president and chairman. He also held a number of R&D positions with Salutar and Catalytica Pharmaceuticals and is Cidara Therapeutics’ board chairman. Dr. Rocklage is also on the board of Novira Therapeutics, Rennovia, Kinestral, the Whitehead Institute, Nouscom AG, MDS Proteomics, Semprus BioSciences Corp., Relypsa and Cubist Pharmaceuticals.
Dr. Scott Rocklage has an extensive scientific background, vast experience in healthcare management and an exemplary track record for strategic leadership. He has held executive and directorial positions in a vast number of companies. Currently based in 5AM Venture Management’s Waltham, Massachusetts office, Scott Rocklage has spent the past 30 years working with entrepreneurs who are scientists, physicians or business executives helping them shape their ideas into medicines to address unmet medical needs. He’s excited about the explosive growth of targeted cancer treatments that save, extend and improve the quality of people’s lives.
One of the reasons Dr. Rocklage has been so successful is because he’s very well organized when it comes to calendaring, prioritization and time management. He advises budding entrepreneurs to embrace measured risk-taking if they want to succeed. Dr. Scott Rocklage also recommends reading “Good to Great” to better understand business and performance.
Connect with Dr. Scott Rocklage on LinkedIn.